In both estrogen receptor (ER)-positive (MCF-7) and ER-negative (MDA-MB-231) breast cancer cells, EGCG also increases the binding of hTERT repressor E2F-1 to its promoter [79]. This evidence concerns the gene ESR1 and breast carcinoma.